Stock Scorecard



Stock Summary for Jasper Therapeutics Inc (JSPR) - $22.11 as of 4/23/2024 8:35:13 PM EST

Total Score

13 out of 29

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for JSPR

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for JSPR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for JSPR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for JSPR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for JSPR

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference 4/2/2024 8:30:00 PM
Jasper Therapeutics ( JSPR ) Is a Great Choice for 'Trend' Investors, Here's Why 3/22/2024 12:50:00 PM
Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference - Jasper Therapeutics ( NASDAQ:JSPR ) 3/21/2024 8:30:00 PM
Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference 3/21/2024 8:30:00 PM
Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria 3/19/2024 12:00:00 PM
New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia 3/15/2024 12:00:00 PM
Jasper Therapeutics, Inc. ( JSPR ) Is Up 24.77% in One Week: What You Should Know 3/14/2024 4:00:00 PM
Here's Why Momentum in Jasper Therapeutics, Inc. ( JSPR ) Should Keep going 3/6/2024 1:50:00 PM
Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments 3/4/2024 12:30:00 PM
Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference - Jasper Therapeutics ( NASDAQ:JSPR ) 2/26/2024 9:30:00 PM

Financial Details for JSPR

Company Overview

Ticker JSPR
Company Name Jasper Therapeutics Inc
Country USA
Description N/A
Sector Name REAL ESTATE & CONSTRUCTION
Industry Name BLANK CHECKS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/10/2024

Stock Price History

Last Day Price 22.11
Last Day Price Updated 4/23/2024 8:35:13 PM EST
Last Day Volume 77,661
Average Daily Volume 101,235
52-Week High 31.01
52-Week Low 4.00
Last Price to 52 Week Low 452.75%

Valuation Measures

Trailing PE N/A
Industry PE 86.62
Sector PE 64.00
5-Year Average PE -10.52
Free Cash Flow Ratio 3.83
Industry Free Cash Flow Ratio 275.42
Sector Free Cash Flow Ratio 173.45
Current Ratio Most Recent Quarter 7.19
Total Cash Per Share 5.77
Book Value Per Share Most Recent Quarter 7.03
Price to Book Ratio 5.34
Industry Price to Book Ratio 3.03
Sector Price to Book Ratio 3.50
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 0.54
Sector Price to Sales Ratio Twelve Trailing Months 3.42

Share Statistics

Total Shares Outstanding 15,063,900
Market Capitalization 333,062,829
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -71.06%
Reported EPS 12 Trailing Months -61.80
Reported EPS Past Year 0.00
Reported EPS Prior Year -1.97
Net Income Twelve Trailing Months -64,405,000
Net Income Past Year -64,465,000
Net Income Prior Year -37,685,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 159.65%

Balance Sheet

Total Cash Most Recent Quarter 86,900,000
Total Cash Past Year 86,900,000
Total Cash Prior Year 38,250,000
Net Cash Position Most Recent Quarter 86,900,000
Net Cash Position Past Year 86,882,000
Long Term Debt Past Year 18,000
Long Term Debt Prior Year 18,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 78,440,000
Total Stockholder Equity Prior Year 35,989,000
Total Stockholder Equity Most Recent Quarter 78,440,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.40
MACD Signal 1.31
20-Day Bollinger Lower Band -0.71
20-Day Bollinger Middle Band 17.19
20-Day Bollinger Upper Band 35.09
Beta 2.22
RSI 40.82
50-Day SMA 13.72
200-Day SMA 0.00

System

Modified 4/23/2024 3:51:35 AM EST